IJPR.2022.161

Type of Article:  Original Research

Volume 10; Issue 5 (October 2022)

Page No.: 4389-4394

DOI: https://dx.doi.org/10.16965/ijpr.2022.161

Benefits of Pulmonary Rehabilitation in Post COVID Patients: A Retrospective Study

Reeta Chippa *¹, Lavanya Ayyer ².

¹ Intern, LSFPEF’s College of Physiotherapy, Nigdi, Pune, Maharashtra, India.

²Assistant Professor of Neurophysiotherapy, LSFPEF’s College of Physiotherapy, Nigdi, Pune, Maharashtra, India.

Corresponding Author: Reeta Chippa, Intern, LSFPEF’s College of Physiotherapy, Nigdi, Pune, Maharashtra, India. E-Mail: chippareeta956@gmail.com 

ORCiD:

Reeta Chippa: 0000-0002-9418-7237

ABSTRACT

Background: covid-19 disease has spread worldwide irrespective of age, gender and comorbidities. lung is the main affecting organ in corona virus disease due to which patients infected with covid19 has impacting on exercise tolerance, quality of life and dyspnoea.

Purpose: to observe the effects of pulmonary rehabilitation in post covid patients.

Objectives: to observe the effects of pulmonary rehabilitation of dyspnoea by MMRC scale and exercise tolerance by 6min walk test in post covid patients.

Methodology: A total of 61 patients meeting the inclusion and exclusion criteria. dyspnoea and exercise tolerance score has recorded before and after the pulmonary rehabilitation.

Result: post pulmonary rehabilitation score in terms of dyspnoea and exercise tolerance has showed extremely significant improvement (p<0.001) as compared to pre pulmonary rehabilitation score.

Conclusion: pulmonary rehabilitation is effective in improving dyspnoea and exercise tolerance in post covid patients.

KEYWORDS: Pulmonary Rehabilitation, Covid-19, Exercise Tolerance, Dyspnoea.

REFERENCES

[1]. Liu PP, Blet A, Smyth D, Li H, The science underlying COVID19: implications for the cardiovascular system. Circulation. 2020;142(1):68-78.
[2]. Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol 2020;15:700-4.
[3]. Andersen KG, Rambaut A, Lipkin WI, et al. The proximal origin of SARS-CoV-2. Nat Med. 2020;26: 450–452.
[4]. Leung NHL, Chu DKW, Shiu EYC, et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nature Med. 2020;26(5):676–68
[5]. Han Q, Lin Q, Ni Z, et al. Uncertainties about the transmission routes of 2019 novel coronavirus. Influenza Other Respir Viruses. 2020;14(4):470–471.
[6]. Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020;382(10):929–936.
[7]. To KK, Tsang OT, Chik-Yan Yip C, et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis. 2020.
[8]. Liu L, Wei Q, Alvarez X, et al. Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tractsof rhesus macaques. J Virol. 2011;85(8):4025–4030.
[9]. Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020. Euro Surveill. 2020;25(5):2000062.
[10]. Lauer SA, Grantz KH, Bi Q, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020;172(9):577–582.
[11]. The White House. Press Briefing by Members of the President’s Coronavirus Task Force;2020 ;(1)
[12]. European Centre for Disease Prevention and Control. Algorithm for the management of contacts of probable or confirmed COVID-19 cases; 2020 Feb 25
[13]. Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RTPCR. Euro Surveill. 2020;25(3):2000045.
[14]. Reusken C, Broberg EK, Haagmans B, et al. Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries. Euro Surveill. 2020;25(6):2000082.
[15]. Hans Bösmüller1 & Matthias Matter2 & Falko Fend1 & Alexandar Tzankov2 The pulmonary pathology of COVID-19, 2019;(19).
[16]. Gagliardi MC, Tieri P, Ortona E and Ruggieri A. ACE2 expression and sex disparity in COVID-19. Cell Death Discov 2020;6:37.
[17]. Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X.; et al. Clinical features of patients infected with 2019 novel coronavirus in wuhan, china. Lancet 2020;395:497–506.
[18]. Guan, W.J.; Ni, Z.Y.; Hu, Y.; Liang, W.H.; Ou, C.Q.; He, J.X.; Liu, L.; Shan, H.; Lei, C.L.; Hui, D.S.C.; et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 2020;382;1708–1720.
[19]. Bhatraju, P.K.; Ghassemieh, B.J.; Nichols, M.; Kim, R.; Jerome, K.R.; Nalla, A.K.; Greninger, A.L.; Pipavath, S.; Wurfel, M.M.; Evans, L.; et al. Covid-19 in Critically Ill Patients in the Seattle Region-Case Series. N. Engl. J. Med. 2020;382:2012–2022.
[20]. Sun, Z.; Zhang, N.; Li, Y.; Xu, X. A systematic review of chest imaging findings in COVID-19. Quant. Imaging Med. Surg. 2020;10:1058–1079.
[21]. Mao, L.; Jin, H.; Wang, M.; Hu, Y.; Chen, S.; He, Q.; Chang, J.; Hong, C.; Zhou, Y.; Wang, D.; et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683.
[22]. Hermann, M.; Pekacka-Egli, A.-M.; Witassek, F.; Baumgaertner, R.; Schoendorf, S.; Spielmanns, M. Feasibility and Efficacy of Cardiopulmonary Rehabilitation following COVID-19. Am. J. Phys. Med. Rehabil. 2020;99:865–869.
[23]. Xiang, Y.-T.; Yang, Y.; Li, W.; Zhang, L.; Zhang, Q.; Cheung, T.; Ng, C.H. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psychiatry 2020;7:228–229.
[24]. Cooper, C.B. Exercise in chronic pulmonary disease: Aerobic exercise prescription. Med. Sci. SportsExerc. 2001;33:S671–S679.
[25]. Spruit, M.A.; Singh, S.J.; Garvey, C.; ZuWallack, R.; Nici, L.; Rochester, C.; Hill, K.; Holland, A.E.; Lareau, S.C.; Man, W.D.-C.; et al. An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation. Am. J. Respir. Crit. Care Med. 2013;188:e13–e64.
[26]. Borg, G.A. Psychophysical bases of perceived exertion. Med. Sci. Sports Exerc. 1982;14:377–381.
[27]. Ellen Hillegass essentials of cardiorespiratory physiotherapy, fourth edition.
[28]. Gloeckl R, Leitl D, Jarosch I, et al. Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study. ERJ Open Res2021; 7:00108-2021

Share this Research

Facebook

Twitter

Linkedin

email

Print

Pinterest